| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTLA | Common Stock | Sale | $6,689 | -556 | -0.77% | $12.03 | 71,470 | 02 Jan 2025 | Direct | F1 |
| transaction | NTLA | Common Stock | Sale | $90,400 | -7,422 | -10% | $12.18 | 64,048 | 03 Jan 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Sale of 556 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2024. |
| F2 | Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person. |